Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/ekaqCfbwocfbhypJcbvb

February 11, 2013
Sign upForwardArchive
News for the PBM Industry

  Featured Stories 
  • PCMA: State biosimilar laws will raise costs
    Enacting laws at the state level that would restrict the substitution of biosimilar drugs would raise costs for patients and employers and compete with forthcoming federal laws, the Pharmaceutical Care Management Association says. "Creating a patchwork of dueling state and federal rules would make it harder for pharmacists to know when they can dispense a biosimilar," according to PCMA. "That would raise costs for patients and their employers, who typically cover two-thirds of prescription drug benefit costs." AIS Health/Specialty Pharmacy News (2/8) LinkedInFacebookTwitterEmail this Story
  Legislative & Regulatory News 
  PBM Industry News 
  Drug Industry Spotlight 
  • Macleods gets FDA nod for generic Actos
    Macleods Pharma received FDA approval for its pioglitazone hydrochloride tablets in three strengths: 15 mg, 30 mg and 45 mg. The drug is a generic formulation of the diabetes treatment Actos, made by Takeda. Drug Store News (2/8) LinkedInFacebookTwitterEmail this Story
  SmartQuote 
The only man I know who behaves sensibly is my tailor; he takes my measurements anew each time he sees me. ... The rest go on with their old measurements and expect me to fit them."
--George Bernard Shaw,
Irish playwright


LinkedInFacebookTwitter

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

 
Contact PCMA
Charles Cote
Assistant Vice President, Strategic Communications
(202) 207-3610

Twitter  Follow PCMA on Twitter
 
About PCMA
PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 210 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D. PCMA is dedicated to enhancing the proven tools and techniques pioneered by PBMs that generate savings and access for consumers and payors.

 
 Recent PCMA SmartBrief Issues:   Lead Editor:  Melissa Turner
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.® Legal Information